Blood vessel control of macrophage maturation promotes arteriogenesis in ischemia by Krishnasamy, Kashyap et al.
ARTICLE
Blood vessel control of macrophage maturation
promotes arteriogenesis in ischemia
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Ischemia causes an inﬂammatory response that is intended to restore perfusion and
homeostasis yet often aggravates damage. Here we show, using conditional genetic deletion
strategies together with adoptive cell transfer experiments in a mouse model of hind limb
ischemia, that blood vessels control macrophage differentiation and maturation from
recruited monocytes via Notch signaling, which in turn promotes arteriogenesis and tissue
repair. Macrophage maturation is controlled by Notch ligand Dll1 expressed in vascular
endothelial cells of arteries and requires macrophage canonical Notch signaling via
Rbpj, which simultaneously suppresses an inﬂammatory macrophage fate. Conversely,
conditional mutant mice lacking Dll1 or Rbpj show proliferation and transient accumulation of
inﬂammatory macrophages, which antagonizes arteriogenesis and tissue repair. Furthermore,
the effects of Notch are sufﬁcient to generate mature macrophages from monocytes ex vivo
that display a stable anti-inﬂammatory phenotype when challenged with pro-inﬂammatory
stimuli. Thus, angiocrine Notch signaling fosters macrophage maturation during ischemia.
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Growth of functional arteries is essential for the restorationof blood ﬂow to ischemic limbs and organs. Ischemiacauses an inﬂammatory response that is intended to
initiate restoration of perfusion and tissue repair yet often
aggravates damage or disturbs healing1, 2. Monocytes and
macrophages in particular are recruited to ischemic vessels and
tissues and are essential for remodeling of small collateral vessels
into conduit arteries, or arteriogenesis, a process capable of fully
restoring blood ﬂow3.
Macrophages have diverse phenotypes and functions in
different contexts, ranging from pro-inﬂammatory states with
detrimental effects on tissues in host defense to trophic or
reparative roles, as described in arteriogenesis4, 5. Macrophage
diversity is considered to arise from combinations of differentia-
tion and activation or polarization programs6. Differentiation
programs induce a stable and irreversible transition and matura-
tion from macrophage precursors to distinct macrophage lineages
under the control of external lineage factors, such as macrophage
colony stimulating factor (CSF1) or granulocyte-macrophage CSF
(CSF2)7. These cooperate with mostly unknown tissue-speciﬁc
identity signals6, which can ultimately lead to terminal macro-
phage differentiation mediated by Ets repressor Etv3 (METS),
which induces cell cycle arrest by suppressing Myc8. In contrast,
activation programs induce mostly reversible changes in response
to cytokines or danger signals6. This plasticity was initially termed
polarization9, describing essentially pro- and anti-inﬂammatory
fates, but was recently revised into a spectrum model of activation,
recognizing that the number of stimuli and resultant activation
programs is not dichotomous, but rather more diverse10. In a
model of myocardial infarction, it was recently shown that the
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Fig. 1 Origin of macrophages in ischemia. a Representative ﬂow cytometric analysis of ischemic tibialis anterior muscle of Cx3cr1GFP/+ mice. Granulocytes
(green), Ly6Chi monocytes (blue) and macrophages (black), n= 3 mice/group. b Adoptive cell transfer at d1 after HLI and cell fate tracking of CD45.2
+CD11b+GFP+Ly6Chi monocytes transferred into CD45.1+ recipients. Representative ﬂow cytometry of recipient muscle, replicated at least three times.
c Treatment with CCR2 blocking antibody MC-21 (α) or isotype control c for indicated time intervals (r × d) after HLI and analysis of cell populations in
peripheral blood (PB) and muscle (M) by ﬂow cytometry. n= 5/7/7 mice/group, error bars represent s.e.m. ***p< 0.001, **p< 0.01, *p< 0.05 *indicates
comparison between treatment with MC-21 (α) vs isotype control c by one way ANOVA with Bonferroni multiple comparison test. d Quantitative RT-PCR
analysis of cell populations of Cx3cr1GFP/+ mice sorted from d3 ischemic muscle relative to bone marrow (BM) Ly6Chi monocytes. n= 3 independent
experiments, error bars represent s.e.m. ***p< 0.001, **p< 0.01, *p< 0.05, #Comparison between muscle and BM Ly6Chi cells, *Comparison between
muscle Ly6Chi and muscle macrophages (MF), one way ANOVA with Bonferroni multiple comparison post-test
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subset of Ly6Chi monocytes is recruited to ischemic tissues and
differentiates into macrophages, which is required for cardiac
healing, since impaired differentiation lead to adverse cardiac
remodeling11. Exactly how macrophage differentiation and
function is regulated during ischemia and arteriogenesis still
remains largely unknown.
Organ-speciﬁc endothelial cells (EC) exert angiocrine functions
that are involved in homeostasis and tissue regeneration inde-
pendent of blood ﬂow12. After injury, instructive cues expressed
by local EC orchestrate the injury response of tissue-resident or
hematopoietic progenitor cells and ﬁbroblasts during organ
regeneration, which in part is mediated by endothelial-speciﬁc
expression of Notch ligands such as Jagged-113–15.
Notch signaling is a cell to cell contact-dependent signaling
pathway regulating vascular development, branching morpho-
genesis, and homeostasis16–18. Activation of Notch receptors is
controlled by membrane-bound Notch ligands of the Jagged (Jag)
and Delta-like (Dll) gene families, which show different Notch
receptor binding afﬁnities and tissue expression patterns, thereby
controlling speciﬁc Notch signaling outcomes19. The Notch
ligand Dll1 is selectively expressed in vascular EC, and Dll1
haploinsufﬁciency leads to severely impaired arteriogenesis
and ischemic tissue damage in a mouse model of hind limb
ischemia20. We recently described that Notch signaling activated
by endothelial Dll1 regulates cell fate of monocyte subsets under
steady state conditions21.
We now tested the hypothesis that endothelial Dll1 mediates
angiocrine effects in arteriogenesis by inﬂuencing macrophages
in a mouse model of hind limb ischemia22. We show that
endothelial Dll1 regulates macrophage differentiation and
maturation from invading Ly6Chi monocytes, which promotes
arteriogenesis and tissue repair after ischemia.
Results
Macrophages develop from Ly6Chi monocytes in ischemia. To
study the origin and regulation of macrophages in response to
peripheral tissue ischemia, we ﬁrst characterized the population
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Fig. 2 Ischemia triggers induction of Notch ligand Dll1 in arteries. a Quantitative RT-PCR analysis of cell populations of Cx3cr1GFP/+ mice sorted from
d3 ischemic muscle relative to bone marrow (BM) Ly6Chi monocytes. n= 3 independent experiments, error bars represent s.e.m. ***p< 0.001, **p< 0.01,
*p< 0.05 #Comparison between muscle and BM Ly6Chi cells, *Comparison between muscle Ly6Chi and macrophages (MF), One way ANOVA with
Bonferroni multiple comparison post-test b Quantitative RT-PCR analysis of ischemic muscle at indicated time points d. n= 3/4/4/4 mice/group, error
bars represent s.e.m., one way ANOVA with Dunnett's Multiple Comparison test. c β-galactosidase activity (blue) and CD45 immunohistochemistry (red)
in ischemic muscle from Dll1+/lacZ reporter mice. Scale bars=50 µm. d Representative immunostaining and confocal microscopy of collateral arteries in
Cx3cr1GFP/+ mice after HLI. Phase contrast image (GFP) × 5, scale bar=200 µm. Confocal images with anti-SMA × 40, CD31 × 40 and × 63. Nuclear
counterstain (DAPI, blue). Scale bar=20 µm
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dynamics of monocytes and macrophages by ﬂow cytometry
(for gating and antibody panel see Supplementary Fig. 1 and
Supplementary Table 1) in the mouse model of hind limb
ischemia (HLI)22. We analyzed Cx3cr1GFP/+ reporter mice23, in
which monocyte and macrophages, but not granulocytes, express
distinct intensities of GFP (mouse strain information see
Supplementary Table 2). Ischemia triggered recruitment of
Ly6Chi monocytes into muscle, which was closely followed by
the appearance of macrophages (Fig. 1a, Supplementary Fig. 1).
While the monocyte response was transient, macrophage
development was more sustained and characterized by
gradual down regulation of Ly6C and up regulation of Cx3cr1,
CD11c, and MHC class II over time, suggesting maturation of
macrophages from monocytes.
After myocardial infarction, cardiac macrophages are reported
to develop from Ly6Chi monocytes and mediate healing11. To
conﬁrm and extend these ﬁndings we performed adoptive
transfer studies with Ly6Chi monocytes that were isolated from
CD45.2+ Cx3cr1GFP/+ mice (Supplementary Fig. 2a) and
intravenously transferred into CD45.1+ recipient mice 1 day after
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induction of hindlimb ischemia. Cell fate of donor cells,
distinguished from recipient by expression of GFP and congenic
CD45, was analyzed by ﬂow cytometry 1, 2, and 6 days after
transfer in ischemic limb muscle. Transferred Ly6Chi monocytes
gradually and uniformly adopted a macrophage phenotype
similar to endogenous macrophages, displaying gradual
downregulation of Ly6C and upregulation of F4/80, Fcγ receptor
CD64 and CD11c integrin over time (Fig. 1b, Supplementary
Fig. 2b). Thus, in ischemic muscle Ly6Chi monocytes give rise to
macrophages, which continue to undergo phenotypic changes
suggesting macrophage maturation over time. In contrast,
donor monocytes retrieved from the spleen of recipient mice
predominantly adopted a Ly6Clo monocyte phenotype, as
previously reported21, which was not even transiently observed
in muscle (Supplementary Fig. 2c, d).
Our data so far suggested that, in ischemic muscle, a wave of
early invading Ly6Chi monocytes gives rise to macrophages that
gradually change their phenotype as they differentiate. We
therefore tested the effects of Ly6Chi monocyte-depletion on the
development of ischemic macrophages using anti-CCR2 antibody
treatment (clone MC-21), which selectively and transiently
depletes Ly6Chi monocytes24. We speciﬁcally addressed the
effects of early vs. delayed monocyte depletion on the kinetics
of macrophage development after ischemia. With an early
depletion strategy (d0–d4 after HLI), MC-21 treatment strongly
depleted Ly6Chi monocytes from peripheral blood (PB) and
muscle at day 3 and also dramatically reduced the number of
macrophages at this time point (Fig. 1c). At d7, Ly6Chi monocyte
levels in PB recovered, reﬂecting the transient nature of monocyte
depletion, while Ly6Chi monocyte numbers in muscle were
increased but numbers of macrophages were still strongly reduced
compared with isotype control (Fig. 1c). In contrast, delayed
antibody treatment (from d4 onwards) reduced the number of
Ly6Chi monocytes in PB, but did not signiﬁcantly affect the
number of ischemic macrophages at day 7. Thus, while initial
depletion of Ly6Chi monocytes impairs early and late macrophage
populations, delayed monocyte depletion does not inﬂuence
macrophage development. These data clearly demonstrate
that early invading Ly6Chi monocytes give rise to ischemic
macrophages, which continue to change their phenotype as they
develop over time.
We next characterized the gene expression changes occurring
during monocyte-to-macrophage differentiation in ischemic
muscle. We isolated Ly6Chi monocytes and macrophages from
ischemic muscle and compared the gene expression signatures
with naive Ly6Chi monocytes from the bone marrow (BM) of the
same mouse. Compared with BM Ly6Chi monocytes, ischemic
muscle Ly6Chi monocytes showed signiﬁcant upregulation of
transcription factor Mafb, involved in macrophage differentiation
from precursors, and the macrophage marker Mer tyrosine kinase
receptor (Mertk) (Fig. 1d)25. On the other hand, compared with
muscle monocytes, ischemic macrophages showed signiﬁcantly
elevated levels of genes involved in macrophage differentiation
(Mafb, Scavenger receptor Sra) and maturation, indicated by
suppression ofMyc but high expression of the transcription factor
Etv3, which regulates terminal macrophage differentiation by
suppressing Myc (Fig. 1d)8. At the same time, macrophages
showed upregulation of Mannose receptor Mrc1 and Mertk, and
high expression of anti-inﬂammatory Il10 and low expression of
inﬂammatory cytokines Il6 and Il12, a proﬁle consistent with
reparative macrophages. Altogether, these data demonstrate that
ischemic macrophages develop from Ly6Chi monocytes by
gradual differentiation and maturation.
Dll1 promotes macrophage differentiation. We also compared
expression patterns of Notch target genes in BM monocytes and
ischemic monocytes and macrophages. The Notch target genes
Hey1 and Hes1 were markedly upregulated in cells isolated
from ischemic muscle, showing the highest expression levels in
macrophages (Fig. 2a). This indicates active Notch signaling
during macrophage differentiation in ischemic tissues. At the
same time, expression of the Notch ligand Delta-like 1 (Dll1)
was increased in ischemic muscle with a timecourse matching
the appearance of macrophages (Fig. 2b). Analysis of ischemic
muscle sections of Dll1+/lacZ reporter mice conﬁrmed our
previous observation that Dll1 expression is restricted to arteries
(Fig. 2c)20. To capture a possible interaction between macro-
phages and blood vessels we performed HLI in Cx3cr1GFP/+
reporter mice, followed by in vivo perfusion ﬁxation and confocal
microscopy. This revealed adhesion of GFP+ cells to the inside of
growing collateral arteries at d3 after HLI, the period of highest
Dll1 expression and macrophage induction (Fig. 2d, Supple-
mentary Fig. 3).
Our in vivo data suggested that Dll1-activated Notch signaling
is involved in ischemic macrophage differentiation from mono-
cytes. To test this under deﬁned conditions in vitro we cultured
Ly6Chi monocytes from Cx3cr1GFP/+ reporter mice on recombi-
nant DLL1. Compared with control conditions, DLL1-activated
Notch signaling in culture (Supplementary Fig. 4a) and generated
CD11b+F4/80+CD115+ macrophages that showed upregulation of
GFP, CD11c, and MHC class II, a phenotype resembling ischemic
tissue macrophages (Fig. 3a, Supplementary Fig. 4b, c). In
contrast, the ligand JAG1 was signiﬁcantly less efﬁcient in
generating this phenotype (Supplementary Fig. 4d). CSF1
was required for these effects, as culture without CSF1 resulted
in low-cell yield, while culture of monocytes with CSF2 resulted
in complete downregulation of F4/80 and GFP regardless of
Fig. 3 DLL1 instruct macrophage maturation in vitro. a Flow cytometry of Ly6Chi monocytes from Cx3cr1GFP/+ mice cultured for 3d on IgG-Fc (con) or
DLL1-Fc chimeric proteins, in the presence of 10 ng/ml CSF1. Representative of n= 5 independent experiments. b Quantitative RT-PCR analysis at d3 after
culture with CSF1, CSF2. n= 2 independent experiments performed in duplicates, error bars represent s.e.m. **p< 0.01, *p< 0.05 by one way ANOVA with
Bonferroni multiple comparison post-test. c Representative analysis of proliferation by 6 h BrdU incorporation at d3. n= 3 independent experiments. d GFP+
cell numbers in culture relative to input number. n= 3 independent experiments performed in duplicates, error bars represent s.e.m. **p< 0.01 by two-way
ANOVA and Bonferroni multiple comparison post-test. e Quantitative RT-PCR analysis normalized to gene expression levels of input Ly6Chi monocytes
(d0). n= 4 independent experiments performed in duplicates, error bars represent s.e.m. ***p< 0.001, **p< 0.01, *p< 0.05 by two way ANOVA with
Bonferroni multiple comparison post-test. f BrdU incorporation in CD11b+ cells at day 7 after 100 ng/ml CSF1 pulse. n= 3 independent experiments, error
bars represent s.e.m. ***p< 0.001 by Student’s unpaired t-test. g Representative Annexin V/7-AAD staining gated on CD11b+ macrophages, n= 3
independent experiments, error bars represent s.e.m, **p< 0.01, Student’s unpaired t test. h Representative ﬂow cytometry of phagocytosis (1 h) of
PE-labeled dextran beads at indicated temperature, d3 of culture. n= 3 independent experiments, error bars represent s.e.m, *p< 0.05, Student’s unpaired
t test. i Multiplex measurement of cytokine concentration in culture supernatant after stimulation with 100 ng/ml LPS (6 h) or combination of 20 ng/ml
IFNγ (18 h) and LPS (6 h). n= 4 independent experiments, error bars represent s.e.m. **p< 0.01, *p< 0.05, Student’s paired t test. j, k Quantitative RT-PCR
analysis after stimulation with IFNγ/LPS normalized to input monocyte levels. Comparison of cells stimulated j at d3 or d6, k with or without re-stimulation
with CSF1 (100 ng/ml) at d6. n= 4 independent experiments in duplicates, error bars represent s.e.m. *p< 0.05 by Student’s paired t-test
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ligand stimulation (Supplementary Fig. 5a, b). Furthermore, cells
cultured on DLL1 in the presence of CSF1 upregulated Mertk and
expressed CD64 and TLR4 (Fig. 3b, Supplementary Fig. 4e), core
macrophage markers, but not the dendritic cell lineage factor
Zbtb4626, indicating macrophage cell fate. In contrast, culture
with CSF2 induced Zbtb46, but not Mertk, regardless of ligand
stimulation (Fig. 3b).
Interestingly, DLL1-generated macrophages mostly remained in
the G0/G1 phase of the cell cycle, had suppressed levels of cyclin-
dependent kinases Cdk1 and Cdk2 and maintained steady cell
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numbers, while control macrophages showed a high-proliferation
rate leading to transient expansion of macrophages in culture
(Fig. 3c, d, Supplementary Fig. 4f). Of note, the effects of DLL1
were not explained by changes in surface expression of the CSF1
receptor (CD115, Supplementary Fig. 4b), but were blocked by the
γ-secretase inhibitor DAPT, which inhibits Notch receptor
activation (Supplementary Fig. 6). Furthermore, DLL1-induced
upregulation of macrophage differentiation markers Mafb and
Sra1, but also marked upregulation of the terminal differentiation
mediator Etv3, and suppression of its downstream repression
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targets, Ets2 andMyc, while the macrophage master regulator Spi1
was not inﬂuenced (Fig. 3e). Our data thus suggested that DLL1
induces a switch from proliferation to differentiation of macro-
phages, indicating a role in macrophage maturation. A hallmark of
(terminally) differentiated cells is cell cycle arrest in response to
growth factor stimulation8. To test whether DLL1 promoted
terminal macrophage differentiation we re-stimulated cells
after 7 days of culture with a CSF1 pulse and quantiﬁed the
proliferation rate. CSF1 induced proliferation in the majority of
control macrophages, while only a small fraction of DLL1-
cultured macrophages started to proliferate (Fig. 3f). In addition,
DLL1-induced maturation was associated with decreased apopto-
sis during prolonged culture, contributing to stable cell numbers
compared with cell loss observed in immature macrophages
(Fig. 3d, g). In functional assays, DLL1 stimulated cells were also
found to be more efﬁcient phagocytes (Fig. 3h). Altogether, these
data demonstrate a DLL1-induced switch between proliferation
and macrophage differentiation.
We next characterized the macrophage inﬂammatory response.
Stimulation of control macrophages with the LPS or LPS/IFN-γ
combination, prototypical inﬂammatory stimuli, induced high
secretion of pro-inﬂammatory cytokines, IL-6, IL-12, and CXCL1,
but low levels of the anti-inﬂammatory cytokine IL-10, which is
in line with the current paradigm of macrophage polarization. In
contrast, DLL1-generated macrophages secreted much lower
levels of pro-inﬂammatory cytokines, but very high levels of IL-10
(Fig. 3i). These results were conﬁrmed on the level of messenger
RNA (mRNA) proﬁles, which also revealed upregulation of Arg1
and strong suppression of inducible nitric oxide synthase (Nos2),
Cxcl1, and Cxcl2 by DLL1 (Supplementary Fig. 7). Thus, DLL1
promotes macrophage maturation, which results in enhanced
phagocytic capacity and anti-inﬂammatory activation even in
response to pro-inﬂammatory stimuli. To test the principle
association between maturation and anti-inﬂammation without
the inﬂuence of DLL1 we ﬁrst compared the inﬂammatory
response of early (d3) vs. mature macrophages (d6),
as macrophage differentiation progresses over time (Fig. 3d,
Supplementary Fig. 8). When stimulated with LPS/IFN-γ, mature
macrophages produced less inﬂammatory cytokines (Fig. 3j). In
contrast, pulsing mature macrophages with CSF1 induces down-
regulation of the differentiation regulator Etv3, proliferation, and
increased inﬂammatory responses in response to LPS/IFN-γ
(Fig. 3f, k). Altogether, these data demonstrate that macrophage
maturation inﬂuences the inﬂammatory response.
Endothelial cells regulate macrophage differentation in vitro.
Our in vivo observations suggested that ischemia generates a
transient niche of Dll1 expressed by arterial EC. Studies with
cultured human primary EC from different vascular domains
conﬁrmed that arterial EC expressed higher levels of DLL1
compared with microvascular ECs (Fig. 4a), while levels of Notch
ligands DLL4 and JAG1 were comparable (Supplementary
Fig. 9a). As EC have been shown to promote macrophage
polarization27, 28, we tested the hypothesis that EC induce
macrophage maturation via DLL1. We ﬁrst conducted co-culture
experiments of human arterial EC together with human PB
CD14+ CD16− monocytes, the human equivalent of murine
Ly6Chi monocytes29, 30, and compared the phenotype to
original donor monocytes (d0 CD14+) or control culture. At d3,
co-cultured CD11b+ cells expressed high levels of CD16, CD163,
CX3CR1, and CD209, a signature consistent with anti-inﬂam-
matory macrophages (Fig. 4b, Supplementary Fig. 10)31.
To address the role of endothelial Dll1 in macrophage
maturation we pretreated EC with a DLL1-speciﬁc siRNA, which
efﬁciently reduced DLL1 expression without altering expression
of other Notch ligands or Notch target genes (Supplementary
Fig. 11a, b). Gene expression analysis of CD11b+ macrophages
retrieved from co-culture revealed suppressed levels of the Notch-
signaling targets HES1, HEY1, but also suppression of genes
associated with macrophage (terminal) differentiation, ETV3 and
MAFB, concomitant with reduced surface expression CD163
(Supplementary Fig. 11c). In addition, expression of IL10 was
reduced, while expression of IL8 was increased (Fig. 4c). Further-
more, DLL1 knockdown in EC also lead to a substantial increase in
macrophage proliferation, indicating that Dll1 suppresses prolifera-
tion and promotes maturation of human macrophages (Fig. 4d).
Arterial EC expressed and secreted signiﬁcantly more CSF1 than
microvascular EC, which in contrast expressed higher levels of
CSF2 (Fig. 4e, Supplementary Fig. 9b). Furthermore, secretion
of CSF1 was required to generate mature macrophages on
arterial EC, as macrophage generation was greatly inhibited by a
CSF1-neutralizing antibody (Fig. 4f). We next reasoned that the
observed differences in Dll1 expression and myeloid growth factor
proﬁles in the two EC populations should have functional
consequences for macrophage instruction. In co-culture experi-
ments comparing arterial vs. microvascular EC, only arterial EC
induced differentiation of CD14+ monocytes to CD16+ CD163+
macrophages (Fig. 4g). Furthermore, macrophages generated on
arterial EC showed signiﬁcantly higher levels of HES1 and MAFB,
and signiﬁcantly reduced levels of MYC, when compared with
either macrophages generated in the presence of microvascular EC
or CSF1 (Fig. 4h). Furthermore, the terminal differentiation
regulator ETV3 was only induced in macrophages generated on
arterial EC. Altogether, these data demonstrate that human arterial
EC have the distinct ability to instruct macrophage differentiation
and maturation from monocytes, which requires Dll1.
EC Dll1 regulates macrophage maturation and arteriogenesis
in vivo. To test the hypothesis that endothelial Dll1 regulates
macrophage maturation after ischemia in vivo we used endothelial-
speciﬁc and inducible Dll1 mutant mice (Dll1iΔEC), which carry
conditional Dll1 alleles and the Cdh5(PAC)-CreERT2 transgene21
Fig. 5 Endothelial Dll1 regulates macrophage maturation and arteriogenesis. a Analysis of cell populations by ﬂow cytometry in ischemic muscle of induced
endothelial Dll1 mutant mice (Dll1iΔEC) and control mice. n= 8 mice/group, error bars represent s.e.m. *p< 0.05 by two way ANOVA with Bonferroni
multiple comparison test. b Gene expression analysis of macrophages sorted from d3 ischemic muscle. n= 3 independent experiments, error bars
represent s.e.m. **p< 0.01, *p< 0.05, Student’s unpaired t-test. c–f Rescue of endothelial Dll1 deﬁciency after HLI by transfer of ischemic macrophages. On
d1 after HLI, indicated groups received intramuscular limb injections of 5 × 10e5 macrophages isolated from d3 ischemic muscle (MF) or Ly6Chi monocytes
isolated from spleen (Mo) of wt mice, or received control treatment. c Foot perfusion by laser Doppler perfusion measurement immediately after induction
of HLI (0) and during follow up. n= 5/7/7/7 mice/group, error bars represent s.e.m. ***p< 0.001 by two way ANOVA and Bonferroni post test.
d Quantiﬁcation of inner circumference and wall area, and representative H&E stained images of collateral arteries d14. Scale bar=50 μm. n= 7 mice/
group, error bars represent s.e.m. ***p< 0.001 vs control by one way ANOVA and Dunnett’s multiple comparison test. e Representative SMA-stained
immunoﬂuorescence of muscle sections, Scale bar 100 μm (left) and quantiﬁcation of arterial branches (SMA+) per section d14, n= 5 mice/group, error
bars represent s.e.m. ***p< 0.001 vs control by one way ANOVA and Dunnett’s multiple comparison test. f Representative H&E stained muscle sections.
Scale bar=50 μm (left) and quantiﬁcation of ghost cells and regenerating muscle ﬁbers (right) at d14, n= 5 mice/group, error bars represent s.e.m.
***p< 0.001 vs control by one way ANOVA and Dunnett’s multiple comparison test
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and which enable targeting under ischemic conditions (Supple-
mentary Fig. 12a, b). Myeloid cell populations were analyzed by
ﬂow cytometry with a non-GFP-based strategy32, which gave
similar results compared with the GFP-based strategy (Supple-
mentary Fig. 13)21. Inducible Dll1 deletion did not change baseline
peripheral leukocyte counts (Supplementary Fig. 14a). Following
HLI, ischemic muscle recruitment of Ly6Chi monocytes or granu-
locytes was not signiﬁcantly altered in conditional Dll1 mutant
mice, as were PB leukocyte counts (Fig. 5a, Supplementary Fig. 14b)
and expression levels of other Notch ligands (Supplementary
Fig. 14c). However, macrophage differentiation kinetics was sub-
stantially altered in Dll1iΔEC mutant mice, showing increased
macrophage numbers initially, followed by a pronounced cell loss
later (Fig. 5a). Gene expression analysis from macrophages isolated
from ischemic muscle of Dll1iΔEC mutant mice revealed signiﬁcant
reductions in macrophage differentiation genes, downregulation of
Il10 and Hey1, but upreguation of inﬂammatory genes Il6 and Il12
(Fig. 5b). Thus, endothelial Dll1 regulates macrophage differentia-
tion and inﬂammatory signature in vivo.
We next addressed the relevance of endothelial Dll1 for
arteriogenesis and ischemic muscle recovery22. To also address the
role of Dll1-dependent macrophage differentiation we designed cell
transfer experiments in which either peripheral Ly6Chi monocytes or
d3 ischemic muscle macrophages from control donor mice were
injected into ischemic limb muscles 1 day after HLI (Supplementary
Fig. 15a, b). Hind limb perfusion measurements by laser Doppler
imaging showed an impairment in foot perfusion in Dll1iΔEC
mutant mice, which was improved by transfer of macrophages,
but not by transfer of monocytes (Fig. 5c). Histomorphometric
analysis of arteriogenesis after HLI showed a signiﬁcant impairment
in luminal and wall growth in collaterals of Dll1iΔEC mutant mice,
which again was rescued by transfer of macrophages, but not
monocytes (Fig. 5d), while Dll1iΔEC mutant mice had no baseline
collateral phenotype (Supplementary Fig. 16a). As ink perfusion
studies also indicated post-ischemic branching defects in Dll1iΔEC
mutant mice (Supplementary Fig. 16b)22 we quantiﬁed the number
of smooth muscle actin (SMA)+ collaterals in ischemic muscle.
There was a signiﬁcant reduction in collateral branch formation in
Dll1iΔEC mutant mice, which was again rescued by transfer of
macrophages, but not monocytes (Fig. 5e). Analysis of capillary
density, in contrast, showed an inverse response compared with
collateral number, suggesting pronounced ischemia in conditions
with reduced collaterals (Supplementary Fig. 16c).
Furthermore, ischemic muscle regeneration was severely
impaired in Dll1iΔEC mutant mice, indicated by a substantial
increase in ghost cells and a signiﬁcant reduction in regenerating
muscle ﬁbers, which was reversed by transfer of macrophages, but
not monocytes (Fig. 5f). Taken together, these results suggest that
blood vessel restricted Dll1 regulates macrophage maturation and
activation state, a function required for arteriogenesis and
ischemic tissue regeneration.
Canonical Notch signaling regulates macrophage maturation.
We next asked whether Notch signaling in macrophages regulates
ischemic macrophage differentiation and tissue recovery in vivo.
We generated mice with conditional ablation of Notch signaling
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in macrophages (RbpjΔM, Supplementary Fig. 17a) to HLI, which
were generated by crossing conditional alleles of the canonical
Notch effector Rbpj33, a myeloid speciﬁc Cre-recombinase,
LysMCre34, and the Cx3cr1GFP/+ reporter. Mice with conditional
deletion of Rbpj had no alteration in circulating granulocytes or
Ly6Chi monocyte numbers at baseline or following HLI, and no
alteration in ischemic muscle recruitment (Fig. 6a, Supplementary
Fig. 17b). However, differentiation of macrophages was severely
altered in conditional Rbpj mutant mice, which showed increased
numbers of proliferating macrophages (Fig. 6a, b) with impaired
upregulation of CD11c and GFP (Fig. 6c). Moreover, gene ex-
pression analysis revealed impaired expression of genes
involved in macrophage maturation (Mafb, Sra), terminal
differentiation (Etv3), and antiinﬂammation (Mrc1, Arg1
and Il10), but upregulation of pro-inﬂammatory Il12 (Fig. 6d).
Notch-deﬁciency also resulted in pronounced macrophage loss
and increased macrophage cell death at later ischemic timepoints
(Fig. 6a, e). Altogether, this phenocopies the kinetics observed
in vitro and in conditional Dll1 mutant mice in vivo.
To corroborate the hypothesis that macrophage maturation
from Ly6Chi monocytes requires Rbpj we cultured wt or
Rbpj-deﬁcient Ly6Chi monocytes on DLL1 and compared
proliferation and gene expression patterns in developing macro-
phages. Mutant Ly6Chi monocytes showed no baseline differences
in Etv3, Mafb, Sra and Myc, and readily gave rise to macrophages
in culture (Fig. 6f). However, induction of genes involved in
macrophage maturation during culture was severly impaired, and
the proliferation rate was signiﬁcantly increased (Fig. 6f, g), thus
demonstrating a requirement for Rbpj in macrophage maturation
from Ly6Chi monocytes.
Laser Doppler perfusion measurements showed impaired foot
perfusion (Fig. 7a) and reduced collateral circulation (Fig. 7b).
Histomorphometric studies revealed impaired arteriogenesis in
Rbpj mutant mice after HLI, but showed no baseline phenotype
(Fig. 7c). This was accompanied by increased ischemic muscle
necrosis (Fig. 7d) and impaired muscle regeneration in
conditional Rbpj mutant mice (Fig. 7e), which resulted in the
development of pronounced muscle ﬁbrosis (Fig. 7f, Supplemen-
tary Fig. 17c).
To test whether the ischemic phenotype of Rbpj-deﬁcient mice
can be rescued by wild type cells we performed HLI in RbpjΔM
mice and intravenously transferred BM Ly6Chi monocytes of
either wild type or RbpjΔM mice. Compared with Rbpj
conditional mutants with control injections, transfer of wild type
monocytes improved the perfusion defects (Fig. 7g), arteriogen-
esis defect (Fig. 7h) and tissue damage (Fig. 7i) following
ischemia, while transfer of Rbpj-deﬁcient monocytes had no
discernible effect.
Overall, these data demonstrate that canonical Notch signaling
controls macrophage maturation from monocytes and inﬂam-
matory polarization, which is required for arteriogenesis and
ischemic tissue repair.
Discussion
We here deﬁne the molecular and cellular context that regulates
the origin and function of macrophages in ischemic neovascu-
larization. Taken together, our results show that blood vessels
regulate macrophage differentiation from recruited monocytes,
which in turn promotes arteriogenesis and ischemic tissue
recovery. Macrophage maturation is controlled by Notch ligand
Dll1 expressed in vascular endothelial cells and requires macro-
phage canonical Notch signaling via Rbpj. Thus, blood vessels
foster macrophages for arteriogenesis in response to ischemia.
The origin and maintenance of macrophages after injury can
occur either through their differentiation from recruited Ly6Chi
monocytes, via local macrophage proliferation or migration of
mature macrophages. Using monocyte cell fate tracking and
timed elimination studies we show that the transient population
of macrophages that arises in ischemic tissues displays a
distinct phenotype and develops from an early invading wave of
Ly6Chi monocytes by way of maturation. This not only speciﬁes
the role of monocytes and macrophages in arteriogenesis4, 5,
but also conﬁrms and extends previous reports that Ly6Chi
monocytes give rise to macrophages during myocardial ischemia
and healing11.
The angiocrine functions of blood vessels, which occur
independent of blood ﬂow, are involved in organ maintenance
and regeneration12. After injury, instructive cues expressed by
local endothelial cells orchestrate the injury response of tissue-
resident progenitor cells or ﬁbroblasts during organ regeneration,
which in part is mediated by endothelial-speciﬁc expression of
Notch ligands such as Jag113–15. We had previously shown that
Dll1, which is upregulated in arterial EC upon ischemia, is an
essential regulator of arteriogenesis and tissue regeneration20.
Our ﬁnding that endothelial Dll1 regulates macrophage matura-
tion in vitro and in vivo, which is required for arteriogenesis and
ischemic tissue regeneration, extends the spectrum of angiocrine
functions towards the setting of ischemic injury, but also
demonstrates that angiocrine signaling via Notch ligand Dll1
supports tissue recovery by instructing maturation of recruited
cell populations. This is further supported by our ﬁnding that
transfer of ‘niche’ educated macrophages improves arteriogenesis
and tissue repair after HLI. Furthermore, these data also clearly
demonstrate a speciﬁc, non-redundant role of vascular Dll1 in
regulating macrophage maturation, which again emphasizes the
ligand-speciﬁc nature of Notch signaling events19. Our data also
support and expand previous reports on how EC populations
cause macrophage polarization28. However, while mature
macrophages seem to mediate most of the downstream vascular
effects of Dll1, our ﬁndings do not necessarily exclude the
possibility of Dll1-dependent, intermediary processes occurring
within blood vessels involved in the ischemic response.
In addition, our ﬁndings also support and extend the concept
of on-site education of VEGF-recruited monocytes for
arteriogenesis, in which Notch has been implicated35. Altogether,
our data clearly demonstrate that angiocrine signaling contributes
to neovascularization and tissue recovery via macrophage
maturation, thus extending the spectrum of endothelial function.
On the other hand, it is possible that dysregulated angiocrine
functions are involved in endothelial dysfunction, which is
thought to mediate the progression of chronic vascular disease36.
Macrophage diversity is considered to arise from a combina-
tion of differentiation programs and activation programs in
response to external stimuli6, 9, 10. Our data contribute to the
current model in several ways. We demonstrate a requirement
for canonical Notch signaling, activated by vascular Dll1,
for macrophage differentiation and maturation from Ly6Chi
monocytes, thus identifying an angiocrine identity factor for
macrophage differentiation. Active Notch signaling promoted a
mature phenotype with enhanced phagocytic activity, a low
proliferation rate in response to CSF1, improved survival and
induction of the terminal differentiation regulator Etv3, thus
demonstrating multiple aspects of mature macrophages8. Of note,
a related function of Notch in promoting myeloid differentiation
has recently been described in myeloid leukemia37. At the same
time, macrophage maturation induced by Notch generated
cells with high-phagocytic abilities, demonstrated in vitro and
suggested by fewer ghost cells in vivo, which also showed an
activation proﬁle consistent with tissue-resident or M2-like
macrophages7, 38. On the other hand, we also demonstrate that
activation/polarization of macrophages and their inﬂammatory
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potential is a function of macrophage maturation. Activation of
mature macrophages instructed by Notch signaling promoted
an anti-inﬂammatory response under conditions that induce
pro-inﬂammatory cytokines in control macrophages. In addition,
the evolution of macrophage maturation over time also
dampened the inﬂammatory response, while re-stimulation with
CSF1 induced proliferation and promoted inﬂammation.
Furthermore, the association between macrophage maturation
and inﬂammatory response was also observed in vivo. This
demonstrates that maturation critically inﬂuences polarization
and suggests a modiﬁed perspective on macrophage diversity.
This hypothesis is also supported by recent ﬁndings from
systematic gene expression proﬁling of monocyte to macrophage
differentiation, which demonstrated that compared with
monocytes, naive macrophages display attenuated innate
inﬂammatory pathways, most likely necessary to generate
functional tissue macrophages39.
Our study, in which ligand, cell-source and growth
factor context were speciﬁcally deﬁned, clearly demonstrates on
several levels an anti-inﬂammatory role of canonical Notch
signaling induced by Dll1, which conﬁrms and extends previous
reports40, 41. However, other studies show a pro-inﬂammatory
role for Dll4/Notch signaling42–44. This suggests that the role of
Notch is ligand-, cell-, and context-speciﬁc, which again
emphasizes the differential effects of speciﬁc ligand-receptor
combinations19. Nevertheless, together the studies now provide a
framework to study the role of Notch signaling components for
macrophage phenotypes in speciﬁc contexts. Currently, the
molecular mediators of Notch in macrophage differentiation and
function are unclear. Importantly, loss of Phd2, the enzyme
controlling HIF-1α activity, has also been shown to induce
macrophage polarization and arteriogenesis5. This would poten-
tially provide a possible mechanism, since Notch and HIF-1α
interact under hypoxic conditions in precursor cells during
development45. The framework described here can also help to
deﬁne the factors by which macrophages promote arteriogenesis.
Further studies clearly are required to address these issues.
Furthermore, the regulation of cell fate choices of Ly6Chi
monocytes are only beginning to emerge. Our cell fate tracking
studies of Ly6Chi monocytes during ischemia revealed that, in
ischemic muscle, monocytes adopt a macrophage cell fate, but that
in other tissues, such as the spleen, cells convert to Ly6Clo mono-
cytes, a process which also requires endothelial Dll121. Thus, while
endothelial Dll1 clearly is required for both processes, our ﬁndings
also suggest that additional, so far unknown, signals ultimately
determine cell fate of Ly6Chi monocytes. These signals might con-
stitute tissue-speciﬁc factors, or pathology-related milieus, or both.
Last but not least, we here describe a cell culture technique for
generation of terminally differentiated macrophages from
monocytes under deﬁned conditions ex vivo. These macrophages
feature a stable anti-inﬂammatory phenotype even when
challenged with pro-inﬂammatory stimuli. This provides a setting
to study and understand the molecular events driving macro-
phage maturation and diversity under deﬁned conditions.
Moreover, since a recent trial in patients with severe heart failure
showed positive results with cell therapy employing an ex vivo
expanded cell product enriched for anti-inﬂammatory ‘M2’
macrophages46, our description might also prove useful to reﬁne
cell-therapeutic applications of ex vivo generated macrophages to
improve chronic ischemia.
Methods
Mice. Experiments were approved by the State Government (LAVES, Lower
Saxony). Mouse strains (Supplementary Table 2) were housed under speciﬁc
pathogen-free conditions. Around 10–12 week old male mice were used with
age- and sex-matched littermate controls.
Mouse strain information. Cx3cr1GFP/+ mice23, Dll1+/LacZ mice47, LysMCre
mice34, Rbpjlox/lox mice33, Dll1lox/lox mice48, Cdh5(PAC)-CreERT2 mice19 have
been described. Gt(ROSA)26Sor (Stock number:003309) mice carrying Cre-indu-
cible lacZ alleles were obtained from The Jackson Laboratories and B6.SJL-
PtprcaPepcb/BoyJ (CD45.1+) (Stock number:002014) mice were obtained from
Charles River. The description of the genetic strains used in the study is described
in Supplementary Table 2.
Hind limb ischemia. Hind limb Ischemia (HLI), laser Doppler imaging, tissue
preparation and analysis of arteriogenesis and muscle sections was carried out as
described22 with the following modiﬁcation: mice were anaesthetized with a
mixture of Ketamine (80 mg/kg, Pﬁzer), Xylazine (2.5 mg/kg, Bayer healthcare),
and Midazolam (2.5 mg/kg, Hexal). Brieﬂy, the superﬁcial branch of the left
femoral artery was surgically ligated distal to the origin of the deep femoral branch,
and growth of pre-existing collateral arteries supplied by the deep femoral branch
was studied in semimembranosus muscle sections. Perfusion was measured by
Laser Doppler Imaging of plantar regions of interests with Perimed LDPI PIM II
Laser Scanner (Perimed, Sweden) and calculated as ratio of left vs. right values. For
ﬂow cytometry cell preparation the anterior tibial muscles were anatomically
excised and digested in DMEM containing 2 mg/ml collagenase II (type 2, derived
from Clostridium histolyticum, Catalog no#LS004176, Worthington Biochemical
Corp.) at 37 °C for 20 min using Gentle MACS dissociator (Miltenyi) and ﬁltered
through a nylon mesh (40 µm), after which total viable cell number was determined
with Trypan blue in a Neubauer chamber.
Animal treatment. Anti-CCR2mAb (MC21)24 or rat IgG2b control antibody was
administered i.p. once a day at a dose of 22.5 µg/mouse, at day 0–2, 0–4, or 4–6
post HLI. Tamoxifen-regulated Cre-recombinase activation was induced as
described21 two weeks before experiments. BrdU (1.5 mg, BD Biosciences) was
injected i.p. and incorporation was detected after 6 h using BrdU ﬂow kit (BD
Biosciences).
Adoptive transfer experiments. Approximately 1–1.5×106 CD11b+GFP+Ly6Chi
monocytes were sorted from the bone marrow of CD45.2 Cx3cr1GFP/+ mice and
injected i.v. into CD45.1 mice 1 day after HLI for cell fate tracking studies. For
ischemic rescue experiments cells were administered i.v. or through intramuscular
injection where indicated. LinnegCD11b+Ly6Chi F4/80/I-Ab/CD11clo/neg splenic
monocytes or LinnegCD11b+ F4/80/I-Ab/CD11c+ macrophages (Supplementary
Table 1) sorted from d3 ischemic muscle were injected through intramuscular
injection into ischemic recipient muscles at d1 after HLI at a dose of 5 × 105 cells in
PBS. In a separate rescue experiment 3 × 106 CD11b+GFP+Ly6Chi monocytes were
administered through i.v. injection.
Tissue histology and immunohistochemistry. Immunohistochemistry, β-galac-
tosidase, and immunoﬂuorescence staining in mice were performed with
modiﬁcations from previous descriptions20–22. Mice were killed and perfused with
0.1% adenosine (Sigma)/0.05% BSA (Roth)/5000 U heparin (Ratiopharm), followed
by ﬁxative 4% PFA (Sigma). Muscles were excised, incubated in 15% (6 h)
and 30% (18 h) sucrose and embedded in Tissue-tek OCT compound (Sakura).
β-galactosidase staining was performed on PFA ﬁxed slides at 37 °C. Slides were
co-stained with anti-mouse CD45 and appropriate alkaline-phosphatase-labeled
secondary antibody, then counterstained with eosin, mounted in Vitro-Clud®
medium (R. Langenbrinck Labortechnik) and analyzed with Olympus IX71
microscope. For immunoﬂuorescence (IF) and confocal laser scanning microscopy
(CLSM) tissue sections were stained using anti-SMA, anti-CD31, and appropriate
ﬂuorescence-conjugated secondary antibodies, DAPI and slides were mounted in
ﬂuorescence mounting medium (DAKO). Detailed information of the antibodies
used can be found in Supplementary Table 5. Whole-mount arterial imaging in
limb muscles was performed with a 160 mg/ml pigment particle solution
(Schmincke, cat. no. HKS 318) infused via the left ventricle. Images were acquired
using Leica TCS SP2 AOBS (Leica Microsystems, Germany) confocal microscope
or Zeiss Observer Z1 ﬂuorescence microscope (Zeiss, Germany) respectively.
Flow cytometry. Single-cell suspensions from tissue homogenates or in vitro
culture were treated with anti-mouse or anti-human CD16/32 (Trustain-fcX,
Biolegend for mouse and FcR Blocking Reagent, Miltenyi Biotec for human) to
prevent non-speciﬁc binding of antibodies to Fc-receptors. To evaluate apoptosis,
cells were stained with 7-AAD and AnnexinV in AnnexinV-binding buffer (all
from BioLegend), according to manufacturer’s protocol. After washing, cells
were re-suspended in PBS containing 2% FCS, 2 mM Na2EDTA and labeled
with primary and secondary antibodies or streptavidin-ﬂuorochrome conjugates
(Supplementary Table 5). After staining, cells were washed twice and stained
with 7-AAD or Propidium Iodide (Sigma) to exclude dead cells in analysis. The cell
suspension was then analyzed on a FACSCalibur or LSR II (BD Biosciences).
Sorting was performed on FACSAria (BD Bioscienses) and XDP (Beckman
Coulter).
For determination of cell numbers per muscle, the complete anterior tibial
muscle was anatomically excised, digested, and total live cell number determined in
a Neubauer chamber with trypan blue staining. After ﬂow cytometry, the number
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of cells per population was determined with the following formula: Trypan blueneg
cells×frequency of live/100.
Phagocytosis assay. Macrophages were washed, resuspended in RPMI with 10%
FCS, and 105 cells were incubated with 1 μm ﬂuoresbrite red latex beads (Poly-
sciences) at a ratio of 10 beads per cell49. The tubes were incubated at 37 °C or on
ice for 1 h, washed and uptake of ﬂuorescent beads was analyzed by ﬂow cytometry.
Quantiﬁcation of cytokines and chemokines. Approximately 50 µL of cell free
supernatants from in vitro cultured macrophages were mixed with 50 µL of the
Bioplex resuspension buffer and concentration of cytokines and chemokines was
determined using Bio-Plex® Mouse cytokine kit (Biorad) on a Luminex 200
according to manufacturer’s instructions.
Murine cell culture and human co-culture experiments. CD11b+GFP+Ly-6Chi
monocytes were sorted from the bone marrow of Cx3cr1GFP/+mice and cultured in
RPMI1640 supplemented with 10% FCS and either 10 ng/ml recombinant murine
CSF1 or CSF2 (Peprotech) based on the experiment. Ligand coating was performed
with 1 µg/ml of DLL1-Fc and JAG1-Fc chimeric proteins where indicated (R&D
Systems) reconstituted in PBS containing 0.1% BSA for 6 h at room temperature.
Recombinant mouse IgG2A-Fc was used as a control. For Notch inhibition assays
cells were treated with DAPT (N-[N-(3,5-Diﬂuorophenacetyl)-L-alanyl]-S-phe-
nylglycine t-butyl ester, 3 µM/ml, Sigma Aldrich, Germany), following cell seeding
on ligands, and was added to the culture every 24 h. DMSO (Sigma Aldrich,
Germany) was added to culture as a control.
Human aortic EC (HAEC, Cat no.: CC-2535), cardiac microvascular EC (MV,
Cat no.: CC-7030) were expanded in EGM-2 and EGM-2MV bullet kit medium, as
recommended by manufacturer (Clonetics Endothelial cell system, Lonza) and
used at P3. Human PB monocytes were isolated with CD14 microbeads
(Miltenyi Biotec) and cultured with EC or human M-CSF (Peprotech, 10 ng/ml)
in medium supplemented with 1% FCS. For co-culture experiments, EC were
seeded at 5000 cells/cm2 and grown for 2 d to form a conﬂuent monolayer.
4 × 104 cells/cm2 CD14+ monocytes were seeded and co-cultured for 24 or 72 h in
EBM2 supplemented with 1% FCS+Gentamycin/Amphotericin. Re-isolation after
co-culture was performed with CD11b microbeads (Miltenyi Biotec). For
estimation of protein levels of CSF1 in co-cultures, 100 µl of the sample aliquots
was used for CSF1 estimation in a solid phase sandwich ELISA (96 well format,
R&D systems) as per manufacturer’s instructions and the optical density was read
at 540 nm. For human CSF1 neutralization experiment, co-cultures were treated
with 2 μg/ml anti–CSF1 mAb (Catalog no #MAB216) or isotype mAb (mouse
monoclonal IgG2A) from R&D biosciences.
siRNA knockdown experiments. For siRNA studies, cells were transfected with
Silencer® Pre-designed siRNA DLL1 (100 nM) (siRNA ID: 133774, Ambion,
Applied Biosystems) using GeneTrans II transfection reagent MoBiTec GmbH).
Scrambled RNA was used as control. Co-culture of monocytes was established 48 h
after transfection.
RNA analysis by real-time quantitative PCR. RNA was isolated with the
Nucleospin II kit (Macherey Nagel) and reverse transcription was done using
Reverse transcriptase Kit (Invitrogen), according to manufacturer’s protocols. For
gene expression analysis, primers were designed using the software Primerquest
(IDT) and PrimerBLAST (NCBI) following general guidelines for primer design.
Quantitative RT-PCR analysis was performed in duplicates for each sample
using Fast start essential green DNA master mix (Roche GmbH) according to
manufacturer’s instructions with primers listed in Supplementary Tables 3 and
4 on Light cycler 96 system (Roche). Murine/Human Rps9 was used as a house-
keeping gene to normalize expression of gene of interest depending on the
experiment. Relative expression was calculated by the comparative CT (2−ΔΔCt
values indicate fold change of the gene of interest in the samples relative to a
selected control, 2−ΔCt values indicate relative expression of gene of interest
between samples normalized to Rps9)50.
Statistical analysis. Results are expressed as mean ± s.e.m. n numbers indicate
biological replicates of experiments performed at least three times unless otherwise
indicated. Comparison between two groups was calculated using unpaired,
two-tailed Student’s t-test or two-tailed paired Student’s t-test with conﬁdence
interval of 95% as indicated. For comparison of multiple experimental groups
either one-way ANOVA or two-way ANOVA was performed where indicated.
Dunnett’s multiple comparision posttest or Bonferroni’s post-test was performed
where indicated after performing multiple comparison with ANOVA when the
overall p value was < 0.05.
Data availability. The authors declare that all the relevant data are available upon
request.
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